159 results on '"Siebuhr, Anne Sofie"'
Search Results
2. Development of a highly sensitive chemiluminescence immunoassay for quantification of aggrecanase-generated ARGS aggrecan fragments in serum
3. Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study
4. Effect of n-3 PUFA on extracellular matrix protein turnover in patients with psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
5. Fibroblasts are not just fibroblasts: clear differences between dermal and pulmonary fibroblasts’ response to fibrotic growth factors
6. Dermal fibroblasts have different extracellular matrix profiles induced by TGF-β, PDGF and IL-6 in a model for skin fibrosis
7. Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis
8. Fibroblasts are not just fibroblasts:clear differences between dermal and pulmonary fibroblasts' response to fibrotic growth factors
9. Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis
10. Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27
11. Objective and noninvasive biochemical markers in rheumatoid arthritis:where are we and where are we going?
12. Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis:a multicentre cohort study
13. Effect of n-3 PUFA on extracellular matrix protein turnover in patients with psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
14. Serological Biomarkers of Joint Tissue Turnover Predict Tocilizumab Response at Baseline
15. Objective and noninvasive biochemical markers in rheumatoid arthritis: where are we and where are we going?
16. Dermal fibroblasts have different extracellular matrix profiles induced by TGF-beta, PDGF and IL-6 in a model for skin fibrosis
17. The Anti-ADAMTS-5 Nanobody® M6495 Protects Cartilage Degradation Ex Vivo
18. Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis
19. Accelerated extracellular matrix remodeling in psoriatic arthritis & value of ECM-related biomarkers
20. Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study
21. FIBROSIS IS NOT JUST FIBROSIS - TGF-B AND PDGF INDUCE DIFFERENT EXTRACELLULAR MATRIX PROFILE: A MODEL OF DERMAL FIBROBLASTS WHICH MIMICS SYSTEMIC SCLEROSIS POTENTIAL FOR EVALUATION OF ANTI-FIBROTIC COMPOUNDS WITH TRANSLATIONAL BIOMARKERS [Meeting Abstract}
22. SEROLOGICAL ASSESSMENT OF THE FIBROTIC INDEX IN SCLEROSIS: A CROSS SECTIONAL STUDY [Meeting Abstract}
23. Matrix Metalloproteinase-dependent turnover of cartilage, synovial membrane, and connective tissue is elevated in rats with collagen induced arthritis
24. Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritis
25. THU0335 FIBROSIS IS NOT JUST FIBROSIS – TGF-î’ AND PDGF INDUCE DIFFERENT EXTRACELLULAR MATRIX PROFILE: A MODEL OF DERMAL FIBROBLASTS WHICH MIMICS SYSTEMIC SCLEROSIS POTENTIAL FOR EVALUATION OF ANTI-FIBROTIC COMPOUNDS WITH TRANSLATIONAL BIOMARKERS
26. FRI0370 ACCELERATED EXTRACELLULAR MATRIX REMODELING IN PSORIATIC ARTHRITIS & VALUE OF ECM-RELATED BIOMARKERS
27. FRI0326 SEROLOGICAL ASSESSMENT OF THE FIBROTIC INDEX IN SCLEROSIS: A CROSS SECTIONAL STUDY
28. Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis – a cross-sectional study
29. Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: A cross-sectional study
30. Citrullinated vimentin and biglycan protein fingerprints as candidate serological biomarkers for disease activity in systemic sclerosis: a pilot study
31. Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: A cross-sectional study
32. Is radiographic progression in radiographic axial spondyloarthritis related to matrix metalloproteinase degradation of extracellular matrix?
33. Development of a Neo-Epitope Specific Assay for Serological Assessment of Type VII Collagen Turnover and Its Relevance in Fibroproliferative Disorders
34. Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo
35. Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo
36. Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort
37. Changes of patient-reported outcomes and protein fingerprint biomarkers after exercise therapy for axial spondyloarthritis
38. Fingerprint biomarkers of type I and III collagen in axial spondyloarthropathy (asSpa) and psoriatic arthritis (PsA).:Association with disease activity and diagnostic capacity
39. Citrullinated vimentin and biglycan protein fingerprints as candidate serological biomarkers for disease activity in systemic sclerosis: a pilot study.
40. Changes of patient-reported outcomes and protein fingerprint biomarkers after exercise therapy for axial spondyloarthritis.
41. Aggrecan Degradation Is Not Just Aggrecan Degradation – A Study of Neo-Epitopes (NITEGE and ARGS) of Aggrecanase Degradation
42. Sensitization and Serological Biomarkers in Knee Osteoarthritis Patients With Different Degrees of Synovitis
43. Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis
44. Intercritical circulating levels of neo-epitopes reflecting matrixmetalloprotease-driven degradation as markers of gout and frequent gout attacks
45. CRP and a biomarker of type I collagen degradation, C1M, can differentiate anti-inflammatory treatment response in ankylosing spondylitis
46. Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study
47. Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort
48. Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27
49. Synovitis biomarkers:ex vivocharacterization of three biomarkers for identification of inflammatory osteoarthritis
50. Serological markers of structural integrity and inflammation is associated with pain in osteoarthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.